Cargando…
Low Expression of Stanniocalcin 1 (STC-1) Protein Is Associated With Poor Clinicopathologic Features of Endometrial Cancer
Stanniocalcin-1 (STC-1) is a glycoprotein hormone involved in diverse biological processes, including regulation of calcium phosphate homeostasis, cell proliferation, apoptosis, inflammation, oxidative stress responses, and cancer development. The role of STC-1 in endometrial cancer (EC) is yet to b...
Autores principales: | Khatun, Masuma, Urpilainen, Elina, Ahtikoski, Anne, Arffman, Riikka K., Pasanen, Annukka, Puistola, Ulla, Tapanainen, Juha S., Andersson, Leif C., Butzow, Ralf, Loukovaara, Mikko, Piltonen, Terhi T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505533/ https://www.ncbi.nlm.nih.gov/pubmed/34650342 http://dx.doi.org/10.3389/pore.2021.1609936 |
Ejemplares similares
-
Women with polycystic ovary syndrome present with altered endometrial expression of stanniocalcin-1(†)
por: Khatun, Masuma, et al.
Publicado: (2020) -
Differential impact of clinicopathological risk factors within the 2 largest ProMisE molecular subgroups of endometrial carcinoma
por: Pasanen, Annukka, et al.
Publicado: (2021) -
No Association Between Statin Use and the Prognosis of Endometrial Cancer in Women With Type 2 Diabetes
por: Urpilainen, Elina, et al.
Publicado: (2021) -
Mismatch repair protein and MLH1 methylation status as predictors of response to adjuvant therapy in endometrial cancer
por: Loukovaara, Mikko, et al.
Publicado: (2021) -
Clinicopathologic vs. Molecular Integrated Prognostication of Endometrial Carcinoma by European Guidelines
por: Loukovaara, Mikko, et al.
Publicado: (2022)